[Federal Register Volume 69, Number 213 (Thursday, November 4, 2004)]
[Notices]
[Pages 64274-64275]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 04-24654]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF COMMERCE

Foreign-Trade Zones Board

[Docket 49-2004]


Foreign-Trade Zone 15--Kansas City, MO, Application for Subzone, 
Pfizer, Inc. (Pharmaceutical Products)

    An application has been submitted to the Foreign-Trade Zones (FTZ) 
Board (the Board), by the Greater Kansas City Foreign Trade Zone, Inc., 
grantee of FTZ 15, requesting special-purpose subzone status for the 
manufacturing facilities of Pfizer, Inc. (Pfizer), in the Lee's Summit, 
Missouri, area, within the Kansas City Missouri Customs port of entry. 
The application was submitted pursuant to the provisions of the 
Foreign-Trade Zones Act, as amended (19 U.S.C. 81a-81u), and the 
regulations of the Board (15 CFR part 400). It was formally filed on 
October 29, 2004.
    Pfizer's plant (104 acres) is located at One Pfizer Way, Lee's 
Summit, Jackson County, Missouri. The facility (approximately 235 
employees) is used for the manufacture, processing, warehousing and 
distribution of pharmaceuticals, as well as for research and 
development activities. Pfizer will use zone procedures at the Lee's 
Summit plant to manufacture Revolution (TM), (HTSUS 3004.90.9103), a 
topical parasiticide for dogs and cats. The activity related to the 
manufacture of Revolution (TM) involves the use of the foreign-sourced 
chemicals butylated hydroxytoluene (HTSUS 2907.19.8000), hydroxylamine 
(HTSUS 2928.00.5000), and selamectin (HTSUS 2932.29.5050), two of which 
are processed at Pfizer's Groton, Connecticut facility, prior to 
shipment to the Lee's Summit facility. A subzone application is 
currently pending with the FTZ Board for Pfizer's Groton facility 
(Docket 45-2004). Foreign-sourced chemicals will account for most of 
the material value of the finished product.
    Zone procedures used at Lee's Summit would exempt Pfizer from 
Customs duty payments on foreign

[[Page 64275]]

input when used in production for export (some 33 percent of 
production). Pfizer expects that export sales will grow to account for 
50 percent of production in the near future. On domestic sales, Pfizer 
would be able to choose the lower duty rate (duty free) that applies to 
the finished product, rather than the duty rate on the foreign-sourced 
chemicals listed above, which are dutiable at rates from 3.7 to 6.5 
percent. The request indicates that the savings from utilizing FTZ 
procedures would help improve the plant's international 
competitiveness.
    In accordance with the Board's regulations, a member of the FTZ 
Staff has been designated examiner to investigate the application and 
report to the Board.
    Public comment on the application is invited from interested 
parties. Submissions (original and 3 copies) shall be addressed to the 
Board's Executive Secretary at one of the following addresses:
    1. Submissions via Express/Package Delivery Services: Foreign-Trade 
Zones Board, U.S. Department of Commerce, Franklin Court Building--
Suite 4100W, 1099 14th Street, NW., Washington, DC 20005; or,
    2. Submissions via the U.S. Postal Service: Foreign-Trade Zones 
Board, U.S. Department of Commerce, FCB--Suite 4100W, 1401 Constitution 
Avenue, NW., Washington, DC 20230.
    The closing period for their receipt is January 3, 2005. Rebuttal 
comments in response to material submitted during the foregoing period 
may be submitted during the subsequent 15-day period (to January 18, 
2005).
    A copy of the application and accompanying exhibits will be 
available during this time for public inspection at the address Number 
1 listed above, and at the U.S. Department of Commerce Export 
Assistance Center, 2345 Grand Boulevard, Suite 650, Kansas City, MO 
64108.

    Dated: October 29, 2004.
Dennis Puccinelli,
Executive Secretary.
[FR Doc. 04-24654 Filed 11-3-04; 8:45 am]
BILLING CODE 3510-DS-P